J&J | JNJ - Dochód Netto





Dochód Netto Zmiana Data
AbbVie USD 3.61B 2.92B 2026-06
Abbott USD 928M 149M 2026-06
Amgen USD 2.38B 556M 2026-06
AstraZeneca USD 2.51B 573M 2026-06
Baxter International USD 126M 141M 2026-06
Bayer EUR 219M 2.54B 2026-06
Becton, Dickinson and Co. USD 377M 688M 2026-06
Biogen USD 97.5M 222M 2026-06
Boston Scientific USD 907M 434M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
CONMED USD 23.07M 9.24M 2026-06
Cooper Companies USD 432.8M 510.7M 2026-06
Dexcom USD 249.1M 49.6M 2026-06
Edwards Lifesciences USD 241.9M 138.8M 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
Globus Medical USD 151.57M 27.27M 2026-06
Insulet USD 95M 3.9M 2026-06
Integra LifeSciences USD 4.48M 9.1M 2026-06
Intuitive Surgical USD 818.1M 3.4M 2026-06
J&J USD 5.53B 299M 2026-06
Medtronic USD 1.47B 227M 2026-06
Merck USD -1.34B 2.9B 2026-06
Merit Medical Systems USD 41M 2.99M 2026-03
Novartis USD 3.26B 108M 2026-06
Pfizer USD -248M 2.94B 2026-06
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 343M 1.27B 2026-06
Stryker USD 1.28B 531M 2026-06
Tandem Diabetes Care USD -21.17M 775K 2026-06
Teva Pharmaceutical Industries USD -576M 945M 2026-06
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06
Zimmer Biomet Holdings USD 198.3M 39.8M 2026-06
Zoetis USD 691M 90M 2026-06